PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,210 | +116.2% | 6,753 | +160.5% | 0.00% | – |
Q2 2023 | $5,184 | +172700.0% | 2,592 | +61.8% | 0.00% | – |
Q1 2023 | $3 | -100.0% | 1,602 | -75.2% | 0.00% | – |
Q1 2022 | $7,000 | – | 6,465 | +8879.2% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 72 | -98.5% | 0.00% | – |
Q2 2021 | $9,000 | +80.0% | 4,658 | +328.1% | 0.00% | – |
Q1 2021 | $5,000 | – | 1,088 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |